Skip to main content
See every side of every news story
Published loading...Updated

Brokerages Set Astrazeneca Plc (NYSE:AZN) Target Price at $206.67

Summary by thecerbatgem.com
Astrazeneca Plc (NYSE:AZN – Get Free Report) has received an average rating of “Moderate Buy” from the eighteen analysts that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have issued a buy rating on the company. The […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

thecerbatgem.com broke the news on Sunday, September 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal